ArticleBMC pediatrics2026
Thoracoscopic management of mediastinal tumors in children: a single-center experience with mid-term outcomes.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMediastinal tumors in children represent a heterogeneous and complex group of diseases with various embryological origins and a relatively high rate of malignancy compared to adults. Thoracoscopic surgery has increasingly been used for both diagnosis and treatment. This study aimed to evaluate the clinical characteristics, imaging findings, and mid-term outcomes of thoracoscopic management of mediastinal tumors in children.
methodsThis retrospective case series included 12 patients diagnosed with mediastinal tumors who underwent thoracoscopic surgery at our hospital from August 2020 to March 2024.
resultsThe mean age at surgery was 7.27 ± 5.69 years (male: female ratio = 2:1). Clinical presentations were diverse, including asymptomatic cases (3), recurrent pneumonia (3), lymphadenopathy or paraneoplastic syndrome (5), and pleural effusion (1). Tumor locations included the anterior superior mediastinum (3 cases), middle mediastinum (3 cases), and posterior mediastinum (6 cases). Four patients (33%) received preoperative chemotherapy. Thoracoscopic procedures included biopsy in 3 patients (mean operative time: 61.67 min) and complete tumor resection in 9 patients (mean operative time: 106 min). The conversion rate to open surgery was 0%. The mean duration of postoperative mechanical ventilation was 1.7 ± 1.2 days, chest tube duration was 3.75 ± 2.92 days, and hospital stay was 11.0 ± 11.2 days. Histopathological findings included neuroblastoma (3 cases), ganglioneuroma (3 cases), lymphoma (3 cases), teratoma (2 cases), and thymoma (1 case). No local recurrence was observed during the 24-month follow-up period.
conclusionsThoracoscopic management is a safe, feasible, and effective approach for the diagnosis and treatment of mediastinal tumors in children, providing a minimally invasive option with favorable clinical recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.